ATF2 contributes to cisplatin resistance in non‐small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway

Publisher: John Wiley & Sons Inc

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.136, Iss.11, 2015-06, pp. : 2598-2609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract